Modification of the EMIT immunoassay for the measurement of unbound mycophenolic acid in plasma.
Evaluation of the performance of a modified Enzyme Multiplied Immunoassay Technique for therapeutic drug monitoring of plasma free mycophenolic acid (fMPA) concentrations. A fMPA assay was developed on a Viva-E analyzer. A study of prior ultrafiltration conditions and analytical validation of the EMIT assay were performed. The method was reliable and reproducible. fMPA levels can be monitored using this EMIT assay with the advantage of being an automated method.